
🚨 New from our team!
CMLS Editors’ Choice Articles
Targeting HIF-2α in glioblastoma reshapes the immune landscape and boosts response to immune checkpoint blockade.
📢 A promising strategy to overcome resistance in GBM immunotherapy.
🧠🔬 Read more: doi.org/10.1007/s00018…
English